食管鳞状细胞癌筛查:近期进展
食管鳞状细胞癌(ESCC)全球最常见,诊断时多为晚期致死亡率高,高危人群分布于亚洲食管癌带(里海至中国北方)及非洲部分地区等地。筛查已在少数地区和髙危人群开展,内镜筛查昂贵且许多高危地区可及性不足。近期基于生物标志物的非内镜筛查进展有望提高食管鳞状上皮不典型增生和早期ESCC筛查的准确性与可及性;开发经济有效、准确且耐受性好的筛查试验并在流行区和高危人群应用,有潜力降低全球死亡率。本综述总结内镜与非内镜筛查模式的近期进展。
要点
- 食管鳞状上皮不典型增生是ESCC的癌前病变。
- 内镜筛查ESCC/食管鳞状上皮不典型增生昂贵,许多高危地区可及性不足。
- 基于生物标志物的非内镜筛查近期进展有望提高筛查准确性与可及性。
核心结论
- 开发经济有效、准确且耐受性好的筛查试验并在流行区和高危人群应用,有潜力降低全球ESCC死亡率。
研究设计与样本
- 综述,总结内镜与非内镜筛查模式的近期进展。
主要发现
- ESCC全球最常见,诊断时多为晚期致死亡率高。
- ESCC在亚洲食管癌带(里海至中国北方)及非洲部分地区最常见,世界其他地区也存在高危人群。
- 筛查已在少数地理区域和高危人群开展,成功程度不一。
- 食管鳞状上皮不典型增生是ESCC的癌前病变。
- 内镜筛查ESCC/食管鳞状上皮不典型增生昂贵,许多高危地区可及性不足。
关键数值与推荐
- 近期基于生物标志物的非内镜筛查进展有望提高食管鳞状上皮不典型增生和早期ESCC筛查的准确性与可及性。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Esophageal squamous cell carcinoma (ESCC) is the most common type of esophageal cancer worldwide, with a high mortality due to advanced stage at diagnosis. Although most common in an area known as the Asian Esophageal Cancer Belt, which extends from the Caspian Sea to northern China, and in parts of Africa, high-risk populations also exist elsewhere in the world. Screening for ESCC has been practiced in a few geographic areas and high-risk populations, with varying levels of success. Esophageal squamous dysplasia is recognized as the precursor lesion for ESCC. Endoscopic screening for ESCC/esophageal squamous dysplasia is expensive and not sufficiently available in many high-risk regions. Recent advances in non-endoscopic screening enhanced by biomarker-based disease detection have raised the prospect of improved accuracy and availability of screening for esophageal squamous dysplasia and early stage ESCC. Development of a cost-effective, accurate, and well-tolerated screening test, if applied in endemic areas and high-risk populations, has the potential to reduce mortality from this deadly disease worldwide. In this review, we summarize recent developments in endoscopic and non-endoscopic screening modalities.
引用
- Codipilly DC, Qin Y, Dawsey SM, et al. Screening for esophageal squamous cell carcinoma: recent advances. Gastrointest Endosc. 2018. PMID: 29709526. doi:10.1016/j.gie.2018.04.2352
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。